CoChat

Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling

Open access
Castellano, Giuseppe, Franzin, Rossana, Stasi, Alessandra, Divella, Chiara, Sallustio, Fabio, Pontrelli, Paola, Lucarelli, Giuseppe, Battaglia, Michele, Staffieri, Francesco, Crovace, Antonio, Stallone, Giovanni, Seelen, Marc, Daha, Mohamed R., Grandaliano, Giuseppe, Gesualdo, Loreto · 2018 · Frontiers in Immunology
Cited by 69

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Pericytes are one of the principal sources of scar-forming myofibroblasts in Chronic Kidneys Disease. However, the modulation of Pericyte-to-Myofibroblast Transdifferentiation (PMT) in the early phases of Acute Kidney Injury (AKI) is poorly understood. Here we investigated the role of complement in inducing PMT after transplantation. Using a swine model of renal Ischemia/Reperfusion (I/R) injury, we found the occurrence of PMT after 24 h of I/R injury, as demonstrated by reduction of PDGFRβ+/NG2+ cells with increase in myofibroblasts marker αSMA. In addition, PMT was associated with significant reduction in peritubular capillary luminal diameter. Treatment by C1-inhibitor (C1-INH) significantly preserved the phenotype of pericytes maintaining microvascular density and capillary lumen area at tubulointerstitial level. In vitro, C5a transdifferentiated human pericytes in myofibroblasts, with increased αSMA expression in stress fibers, collagen I production and decreased of anti-fibrotic protein Id2. The C5a-induced PMT was driven by ERK phosphorylation leading to increase collagen I release that required both non-canonical and canonical TGFβ pathways. These results showed that pericytes are a pivotal target of complement activation leading to a profibrotic maladaptive cellular response. Our studies suggest that C1-INH may be a potential therapeutic strategy to counteract the development of PMT and capillary lumen reduction in I/R injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.01002

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Castellano, G., Franzin, R., Stasi, A., Divella, C., Sallustio, F., Pontrelli, P., Lucarelli, G., Battaglia, M., Staffieri, F., Crovace, A., Stallone, G., Seelen, M., Daha, M. R., Grandaliano, G., & Gesualdo, L.
Venue
Frontiers in Immunology
Published
2018-05-23
Volume
9
Pages
1002-1002
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2804820465
Cited by
69
References
5
FWCI
4.58
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.